Article
Circulating estrogens and estrogens within the breast among postmenopausal BRCA1/2 mutation carriers.
Breast cancer research and treatment - 1 Feb 2014
Loud Jennifer T, Gierach Gretchen L, Veenstra Timothy D, Falk Roni T, Nichols Kathryn, Guttmann Allison, Xu Xia, Greene Mark H, Gail Mitchell H
Abstract excerpt
Accurately quantifying parent estrogens (PE) estrone (E1) and estradiol (E2) and their metabolites (EM) within breast tissue and serum may permit detailed investigations of their contributions to breast carcinogenesis among BRCA1/2 mutation carriers. We conducted a study of PE/EM in serum, nipple aspirate fluid (NAF), and ductal lavage supernatant (DLS) among postmenopausal BRCA1/2 mutation carriers. PE/EM...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
